An MS patient’s story: How Secondary-Progressive MS Puts Me in a Whole New Place
Personal Takes Compared with life with relapsing-remitting MS, SPMS feels like an entirely different environment. By Mona Sen Accepting the changes…
United States Progressive Relapsing Multiple Sclerosis Treatment Market to 2025: New Tech Developments, Advancements, Key Players, Strategies to Boost Industry Growth
Article is more scientific than for the everyday person. However, I am posting this to show, that there are many…
Stuart Schlossman
Natalizumab May Reduce Disease Progression in Multiple Sclerosis
For patients with secondary progressive multiple sclerosis, natalizumab was not superior to placebo for reducing disability progression, according to results published…
Stuart Schlossman
Information concerning Primary progressive MS (PPMS)
PPMS is characterized by worsening neurologic function (accumulation of disability) from the onset of symptoms, without early relapses or remissions. PPMS can be…
Stuart Schlossman
Looking into cognitive impairment in Primary-Progressive Multiple Sclerosis.
Petracca M, et al. Eur J Neurol. 2017. Show full citation Abstract BACKGROUND: Cognitive impairment in primary-progressive multiple sclerosis (PP-MS) is…
Stuart Schlossman
Print Global Experts Publish Recommendations for Overcoming Challenges to Improve Clinical Trials in Progressive MS
October 18, 2017 A special issue of Multiple Sclerosis Journal, sponsored by the International Progressive MS Alliance, has been published, containing ten…
Stuart Schlossman
Long-term disability progression in primary progressive multiple sclerosis: a 15-year study.
Rocca MA, et al. Brain. 2017. Show full citation Abstract Prognostic markers of primary progressive multiple sclerosis evolution are needed.…
Stuart Schlossman
Ocrevus Phase 3 Trial Will Explore How Treatment Works by Viewing Changes in Spinal Fluid
…
Stuart Schlossman
Primary Progressive MS: Myths vs. Facts
…
Stuart Schlossman
Genetics of primary progressive multiple sclerosis
…
Stuart Schlossman
